ADA-SCID (Orchard Therapeutics)

ADA-SCID
(Orchard Therapeutics)

Primary immune deficiency (Metabolic disorder)
Phase II

ADA-SCID

This is a partner's product, where Oxford Biomedica provide process development and bioprocessing. For more information on Orchard Therapeutics products their website.